Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Dolby Laboratories (DLB) Stock Price
Media coverage about Dolby Laboratories (NYSE:DLB) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dolby Laboratories earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned news coverage about the electronics maker an impact score of 44.0684044162547 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news articles that may have impacted Accern’s scoring:
- Netflix aims to make ‘Bright’ a living room blockbuster (NFLX, DLB) (markets.businessinsider.com)
- Insider Selling: Dolby Laboratories (DLB) CEO Sells 11,130 Shares of Stock (americanbankingnews.com)
- $266.20 Million in Sales Expected for Dolby Laboratories (DLB) This Quarter (americanbankingnews.com)
- Insider Selling: Dolby Laboratories (DLB) EVP Sells 4,594 Shares of Stock (americanbankingnews.com)
- Kevin J. Yeaman Sells 17,590 Shares of Dolby Laboratories (DLB) Stock (americanbankingnews.com)
A number of equities analysts recently commented on DLB shares. Zacks Investment Research downgraded Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. Piper Jaffray Companies reiterated a “hold” rating and set a $52.00 price objective (up previously from $49.00) on shares of Dolby Laboratories in a research report on Wednesday, September 13th. B. Riley reiterated a “buy” rating and set a $61.50 price objective on shares of Dolby Laboratories in a research report on Thursday, September 14th. Finally, Dougherty & Co reiterated a “buy” rating and set a $63.00 price objective on shares of Dolby Laboratories in a research report on Wednesday, September 13th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. Dolby Laboratories presently has a consensus rating of “Hold” and an average target price of $60.17.
Shares of Dolby Laboratories (NYSE:DLB) traded down $0.38 during trading on Tuesday, reaching $61.87. The company had a trading volume of 129,954 shares, compared to its average volume of 377,007. Dolby Laboratories has a 52-week low of $44.98 and a 52-week high of $63.34. The stock has a market capitalization of $6,367.43, a P/E ratio of 31.89, a price-to-earnings-growth ratio of 2.31 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Wednesday, October 25th. The electronics maker reported $0.45 EPS for the quarter, topping the Zacks’ consensus estimate of $0.27 by $0.18. Dolby Laboratories had a return on equity of 10.62% and a net margin of 18.66%. The firm had revenue of $242.05 million for the quarter, compared to the consensus estimate of $244.80 million. During the same quarter last year, the business posted $0.37 earnings per share. The firm’s revenue was up 3.9% compared to the same quarter last year. research analysts forecast that Dolby Laboratories will post 2.24 EPS for the current fiscal year.
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 10,000 shares of Dolby Laboratories stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $58.38, for a total value of $583,800.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CMO Bob Borchers sold 50,000 shares of Dolby Laboratories stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $62.72, for a total value of $3,136,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 544,409 shares of company stock worth $33,369,495. 43.74% of the stock is currently owned by company insiders.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.